Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy

NCT01726075 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: COLIRIOBCN070660
DRUG: Placebo
DRUG: Brimonidine

Sponsor

BCN Peptides